graphic/j_jhp00094_fig_001.jpg

©Shutterstock

In the United Kingdom (UK), there are 8,370 registered haemophilia patients, of which 1,982 are children and young people aged <18 years [1]. Haemophilia causes painful, spontaneous and trauma-related bleeding, predominantly in the weight-bearing joints, and can eventually result in joint degradation, pain and arthropathy [2]. The degree of bleeding correlates with the severity of the disease, defined by Biggs and Macfarlane as severe (factor levels of <1 iu/dl), moderate (levels 2-5 iu/dl) and mild (5-50 iu/dl) [3]. Thus, those with severe haemophilia are most clinically affected.

The standard treatment of boys with severe haemophilia in the UK is prophylaxis. Treatment commences following the first bleeding episode, with the aim of establishing ‘full’ prophylaxis as soon as venous access allows [4]. For caregivers of children, this is an onerous time; they are learning about ‘being’ a parent of a child with haemophilia, as well as dealing with the complexities of learning medical skills and attending frequent hospital appointments [5,6,7,8]. This burden of disease management can lead to psychological (stress and coping, anxiety and depression, stigmatization and discrimination) as well as economic concerns [9,10,11].

The impact of haemophilia on the quality of life (QoL) of affected individuals has been well documented in the literature and acknowledged in its treatment [12]. However, there remains a paucity of data about the impact of parenting a child with haemophilia on QoL of parents. It is expected that being a parent of a child with haemophilia will influence QoL, as they will worry and have fears related to the wellbeing of their child. Worries may include that something could happen to the child, future treatments and the long-term future.

As caregiver burden has been accepted by the UK National Institute of Clinical Excellence (NICE) as an outcome measure in other severe diseases, we aim to describe it for the first time as it relates to caregivers of children with haemophilia in the UK [13]. The rationale for this study was to describe caregiver burden and its determinants in parents of children with haemophilia, and how caregiver burden can affect health-related quality of life (HRQoL).

Methods

The study is a single-centre non-interventional pilot study conducted between 2012-2013. Twenty caregivers of children, aged 8-17 years with haemophilia A or B of any severity, were included in the study. Consecutive parent/child dyads were recruited in a purposeful sampling manner.

A study questionnaire was compiled and completed by consecutive child/parent dyads attending routine clinical review. The study questionnaire comprised self-reported generic and disease-specific HRQoL questionnaires and a chronicgeneric instrument for the assessment of caregiver burden. In addition, children completed generic and disease-specific HRQoL questionnaires. Only one parent per child/parent dyad completed the study questionnaire, and did so independently. If the child needed help with the questionnaire, this was given by the study team.

Ethical approval to perform the study was granted by NRES Committee London - Surrey Borders and by the research and development team at Great Ormond Street Hospital/Institute of Child Health (reference number 12/LO/1415).

Parents and children completed a variety of validated instruments for the assessment of health-related quality of life (HRQoL) and caregiver burden.

Health-related quality of life (HRQoL): Parents completed the EQ-5D, a self-reported generic standardised instrument measuring health outcome [14]. It is applicable to a wide range of health conditions and treatments, and provides a simple descriptive profile and single index value for health status. It consists of five questions, each with three answer categories (1=no problem, 2=some problems, 3=severe problems). The EQ-VAS is part of the EQ-5D, asking respondents to rate their overall health status on a standard vertical visual analogue scale (VAS) between 100 (best health imaginable) and 0 (worst health imaginable).

Parents also completed the SF-36 (version 1) [15,16]. The SF-36 is a multi-purpose, short-form health survey with 36 items. It yields an 8-scale profile of functional health and wellbeing scores (‘physical functioning’, ‘role physical functioning’, ‘bodily pain’, ‘general health’, ‘vitality’, ‘social functioning’, ‘role emotional functioning’ and ‘mental health’), as well as psychometrically-based physical (PCS) and mental health (MCS) summary scores. Scores range from 0-100, with high values implying good HRQoL.

Children completed the EQ-5D-Youth (EQ-5D-Y), which is validated for use in children and young people aged 8-17 years, and the Haemo-QoL SF (Short Form), a disease-specific HRQoL questionnaire for children and adolescents with haemophilia aged 4-17 years (with 35 items for children aged 8-17 years) [17,18]. Answer categories were based on a 5-point Likert scale, varying from 1=never to 5=always, with high values indicating a high impairment of HRQoL.

Caregiver burden: The Impact on Family Scale (IOF) measures the impact of chronic childhood disease on the family [19,20]. The questionnaire consists of 27 questions (33 if the family has other children) pertaining to five domains (‘financial support’, ‘social relationships’, ‘siblings’, ‘negative impact’ and ‘coping’). Subscales and the total score are transformed into a value of 0-100, with low values implying a high burden.

Additional information: Sociodemographic data were collected from caregivers, including age (child, parents), living situation, number of children with/without haemophilia, marital status, working and chronic illness of caregiver. Clinical data of children, including type and severity of haemophilia, inhibitor status, bleeding history, treatment regimen, were collected from the medical records.

Statistical analyses: The data were analysed using the IBM SPSS programme (version 23; SPSS Inc, Chicago, Illinois). Data are shown as a mean ± standard deviation, median and range (minimum to maximum). To measure the association between different PRO scales the Pearson Correlation coefficient r was used with r = 1 indicating a perfect positive correlation and r = -1 indicating a perfect negative correlation and r = 0 no correlation at all. Differences concerning sociodemographic and clinical information (single parent, parent with a chronic disease, child with inhibitor, etc.) were tested using univariate ANOVA, Student’s t-test or Chi-square tests, depending on the distribution of the data. High burden was defined based on the median split of the IOF total score (high burden = IOF<67.29) vs. low burden = IOF≥67.29). A p <0.05 was considered statistically significant.

Multiple regression models using the enter method were analysed to assess the impact of children’s and parents’ characteristics on caregiver burden and HRQoL. Caregiver burden and HRQoL were dependent variables, while other variables (other illnesses of the child, working status, number of children with haemophilia, chronic illness of parents and economic impact of haemophilia on the family) were taken as predictors.

Results

Sociodemographic characteristics of caregivers

From the participating twenty caregivers, 80% were mothers with a mean age of 39.8±6.2 years; fathers had a mean age of 44.22±7.4 years. Most caregivers were caring for a child between 8-12 years. In one family, the mother was not living with the child. Most caregivers were married (70%). Three caregivers had a chronic illness (hypertension, hypothyroidism, long-term survivor of childhood acute lymphoblastic leukaemia (ALL) and three children had a second chronic illness (ADHD, autism, hypermobility). Almost all caregivers were working part- or full-time (95%); 50% of those working part-time/not working were doing so because they were caring for their haemophilic child. The majority reported that haemophilia causes an economic impact on the family (55%).

All children had siblings with whom they resided; the mean number of children below 18 years living in each household was 2.5±1.2 (range 1-6), with 1.5±0.8 (range 1-3) of these also having haemophilia (Table 1).

Table 1

Sociodemographic characteristics of parents

SOCIODEMOGRAPHIC CHARACTERISTICS N PERCENTAGE
Who completed the questionnaire Mother 16 80%
Father 4 20%
Marital status Single 1 5%
Married 14 70%
Separated 5 25%
Living situation With both parents 10 50%
Only with mother 9 45%
Only with father 1 5%
Chronic illness of caregiver Yes 3 15.8%
Other chronic illness of child Yes 3 16.7%
Time working Full-time 9 45%
Part-time 10 50%
Not working 1 5%
Haemophilia causes economic impact on family Yes 11 55%
Change of occupation due to haemophilia Yes 4 20%
Who mainly takes care of the child Mother 16 80%
Father 2 10%
Both 2 10%
M±SD MEDIAN (RANGE)
Age mother 39.8±6.2 40.5 (28-52)
Age father 44.22±7.4 42.5 (34-62)
Age child 11.6±2.4 11.5 (8-17)
Children living in the house 2.5±1.2 2 (1-6)
Children with haemophilia living in the house 1.5±0.8 1 (1-3)

Clinical data of children

The mean age of boys in the study was 11.6±2.4 years (range 8-17 years). The majority had haemophilia A (80%), were severely affected (60%), and treated prophylactically (80%). One boy with haemophilia B Leyden was included and was considered as ‘mild’ at the time of the study. 9 boys were on primary prophylaxis, 17 were on home treatment (85%) and 9 usually self-infused (45%). Five boys had had an inhibitor; one was still on daily immune tolerance and had a port-a-cath in situ (Table 2).

Table 2

Clinical data of haemophilic children

CLINICAL DATA N PERCENTAGE
Haemophilia type A 16 80%
B 3 15%
B (Leyden) 1 5%
Haemophilia severity Severe 12 60%
Moderate 4 20%
Mild 4 20%
Treatment regimen On-demand 4 20%
Prophylaxis 16 80%
Type of prophylaxis (n=16) Primary 9 56.3%
Secondary 6 37.5%
Short-term 1 6.2%
Prophylaxis frequency (n=16) Daily 2 12.5%
Five times/week (pre-sport) 2 12.5%
Alternate daily 6 37.5%
Three times/week 4 25%
Twice/week 2 12.5%
Treatment administered Self 9 45%
Family member 9 45%
Hospital staff 2 10%
Venous access Peripheral vein 19 95%
Central line 1 5%
Home treatment Yes 17 85%
Inhibitor Ever 5 25%
Current 1 5%
Joint health Joint bleeds 5 25%
Target joints 1 5%
BMI Underweight 5 25%
Normal weight 11 55%
Overweight 3 15%
Obese 1 5%
M±SD MEDIAN (RANGE)
No. of total bleeds in past 3 months 0.3±0.6 0 (0-2)
No. of joint bleeds in past 3 months 1.25±0.5 1 (1-2)
No. of muscle bleeds in past 3 months 0 0
No. of other bleeds in past 3 months 1 1 (1-1)

HRQoL

Caregivers reported, in general, a good HRQoL, showing highest impairments in the dimensions ‘vitality’ (M=60.0±20.5) and ‘emotional role’ (M=70.37±42.6) of the generic SF-36. Caregivers reported good HRQoL on the generic EQ-VAS (M=82.16±14.8) and on the EQ-5D (M=0.90±0.1).

Children reported good HRQoL on the generic EQ-VAS (M=90.25±10.1) and on the EQ-5D (M=0.81±0.3). They reported in the haemophilia-specific Haemo-QoL SF highest impairments in the dimensions ‘physical health’ (M=31.35±25.9) and ‘treatment’ (M=27.96±26.6).

No difference was found between the EQ-5D of caregivers and the EQ-5D-Y of children. By contrast boys reported better values in the EQ-VAS (Mchild=90.25±10.0 vs. Mparents=82.16±14.8).

Impact of burden

Caregivers showed highest burden related to the disease of their sons in the dimension ‘negative impact’ of the IOF scales (M=60.08±20.7). Primarily, they “worried about what will happen to their child in the future” (65%), “were thinking about not having more children because of the illness” (44.4%), and “were wondering sometimes whether their child should be treated ‘differently’ or the same as a normal child” (35%).

Figure 1

Difference in HRQoL (SF-36) between caregivers with a high and low reported burden (IOF)

graphic/j_jhp00094_fig_002.jpg

Moderate-to-strong correlation was found between the IOF scales and caregivers’ HRQoL (SF-36, EQ-VAS). No correlation was found between the IOF and the EQ-VAS of the children; only one moderate correlation was found between the subscale ‘sibling’ of the IOF and the total score of the Haemo-QoL short form (Table 3).

Table 3

Correlation of the Impact on Family (IOF) scale with HRQoL of caregivers and haemophilic children

SUBJECTS QUESTION- NAIRE DIMENSIONS FINANCIAL SUPPORT SOCIAL RELATIONS SIBLING NEGATIVE IMPACT COPING IOF
r: PEARSON CORRELATION COEFFICIENT
Parents SF-36 Physical functioning - .553 .457 - - .559
Role physical functioning .674 .676 .539 - - .675
Bodily pain .538 .549 - - - .550
General health .550 .713 .589 - - .616
Vitality - .491 .466 - - .475
Social functioning .704 .651 .600 - - .661
Role emotional functioning .498 - - - - -
Mental health .561 .508 .485 - - .540
PCS - - - - - -
MCS .537 .484 .484 - - .520
EQ-5D EQ-5D .502 - - - - -
EQ-VAS .646 .533 .538 - .465 .555
Children Haemo-QoL Haemo-QoL SF - - -.496 - - -
EQ-5D EQ-5D-Y - - .494 - - -
EQ-VAS - - - - - -

[i] IOF: Total Score of Impact of Family Scale; SF-36: generic Short Form Health Survey 36; Haemo-QoL SF: Short Form haemophilia-specific HRQoL questionnaire; EQ-5D: generic health outcome measure

Caregivers who reported a high burden on the IOF (<67.29) had significantly worse HRQoL in the domains ‘bodily pain’ (p<0.028) and ‘social functioning’ (p<0.024) of the SF-36 (see Figure 1) and in the EQ-VAS (Mhigh burden=74.78±16.1 vs. Mlow burden=88.88±10.1) (p<0.034); no difference was found on the EQ-5D.

Differences in impact of burden and HRQoL of caregivers

The greatest impact on perceived caregiver burden and HRQoL was found where caregivers reported that haemophilia causes an economic impact on their family. Significant differences were found in the domains ‘financial support’ (p<0.008), ‘social relations’ (p<0.042) and in the total score of the IOF (p<0.033) (see Figure 2), and in the domains ‘social functioning’ (p<0.002), ‘role emotional functioning’ (p<0.043), ‘mental health’ (p<0.009) and the MCS (p<0.027) of the SF-36.

Figure 2

Difference in caregiver burden (IOF) between caregivers reporting an economic impact on their family and those without economic impact

graphic/j_jhp00094_fig_003.jpg

Caregivers who had a chronic disease reported higher impairments in their HRQoL; significant differences were found in the domains ‘physical functioning’ (p<0.007), ‘bodily pain’ (p<0.025) and the PCS (p<0.049) of the SF-36 and in the EQ-5D (p<0.011) using the Mann-Whitney U-Test (data not presented here).

Further significant differences were found in caregiver HRQoL related to the clinical situation of their child. Caregivers of children with severe haemophilia reported higher impairments in their ‘role emotional functioning’ of the SF-36 (p<.043) and caregivers of children treated prophylactically had a significant better EQ-VAS (p<.023).

There were also significant differences concerning caregivers’ characteristics. Caregivers who changed their occupation due to caring for a child with haemophilia reported higher impairments (Myes=51.39±17.2 vs. Mno=76.11±20.2) in the domain ‘siblings’ of the IOF (p<0.040). Caregivers with more than one child with haemophilia under 18 years living in the house reported a better ‘role emotional functioning’ (p<0.020) and MCS (p<0.025) in the SF-36 than parents with only one child with haemophilia. When two caregivers were taking care of the child, they reported a better PCS in the SF-36 (Mone=52.87±6.4 vs. Mtwo=58.62±4.2) (p<0.039).

No difference was found for age of caregiver, marital status, number of children under 18 years living in the house, working status, number of total bleeds, inhibitors or having children with another chronic disease.

‘Working status’ and ‘economic impact of haemophilia on family’ could explain 57.4% of the variance in the value of caregiver burden (IOF) (F(5,11) = 2.967, p<0.062). ‘Having a child with other chronic illness’, ‘number of children with haemophilia under 18 years living in the house’ and ‘caregiver with chronic disease’ did not significantly predict caregiver burden (Table 4). The same predictors were used to explain the variance of caregivers’ HRQoL; 56.9% of the variance of MCS and 54.3% of the variance of EQ-5D could be explained (Table 4).

Table 4

Multiple linear regression models to predict caregiver burden (IOF) and HRQoL (MCS, EQ-5D)

IOF MCS EQ-5D
PREDICTORS BETA P BETA P BETA P
Working status .561 .029 .173 - .544 .038
Child has other chronic disease .231 - .448 - .232 -
No of children < 18 years with .322 - .437 .082 .261 -
haemophilia in house
Parents have chronic disease .440 .061 -.174 - .483 .050
Haemophilia economic impact .491 .040 .532 .039 .425 .078
on family
R2 57.4% 56.9% 54.3%

[i] IOF: total score of Impact on Family scale

EQ-5D: generic health outcome measure

MCS: Mental Component Score of the generic SF-36 HRQoL questionnaire

R2: value explains how much variance in the analysis is explained by predictor variables

Discussion

This is the first study examining caregiver burden in haemophilia in the UK. In this single centre, caregivers reported the highest burden in the dimension ‘negative impact’ of the generic IOF. High burden had an impact on caregivers’ HRQoL. Caregiver burden was mainly affected by the perceived economic impact on the family or chronic disease of the caregiver. ‘Working status’ and ‘economic impact of haemophilia on family’ were significant predictors of caregiver burden.

In a meta-analysis of parental experience of caring for a child with long-term conditions, parents became physically and emotionally overburdened, which manifested as ‘chronic fatigue, frustration and feeling emotionally challenged’ [21]. By contrast, in our study caregivers were predominantly healthy, with only few reporting chronic illness.

Murphy et al. state that physical and emotional health was negatively impacted by the demands of care-giving, with caregivers describing chronic physical and emotional ailments directly attributable to care-giving. These were most evident amongst mothers, who were most often primary caregivers [22]. In our study, mothers were also predominantly the main caregivers; six were single parents. Weidebusch et al. reported that parents experienced a higher burden due to their child’s haemophilia if they were without partner support [10]. Single mothers have significantly higher levels of vulnerability than married mothers, associated with reduced income and physical and mental health problems, which could not be confirmed in our study [23].

It is difficult for mothers to seek or return to employment due to the demands of haemophilia care [6]. 50% of caregivers in our study who worked part-time did so due to their child’s haemophilia. Shahly et al. reported that caring for those with chronic illness increasingly falls on family caregivers who are vulnerable to the burden of financial strain, with uncompensated family care-giving being an important societal asset that offsets rising formal healthcare costs [24]. In our study, 55% of parents reported a negative economic impact caused by haemophilia. Dekoven et al. found that ‘financial’ aspects and ‘emotional stress’, among other issues, are burdensome for caregivers of haemophilic children, which was confirmed in our study [25].

Caregiver burden was demonstrated in concerns about the future, both in terms of what might happen to caregivers’ current and future children. This aspect has been identified by others [28,10]. Supportive care should be introduced to help parents cope with caring to reduce parental stress, anxiety and burden, which may in turn improve HRQoL of both the caregiver and child. The impact of having a child with haemophilia on HRQoL in our study was only seen in the ‘emotional role’ dimension of the SF-36.

This is a small single-centre study; our findings may not be reproducible and may be affected by the culture of the haemophilia centre, including how children are treated and parents are supported. A multi-centre, international study is planned using a newly developed haemophilia-specific instrument assessing caregiver burden [26].

Conclusion

Caregivers of children with haemophilia reported generally good health and QoL, but having a child with haemophilia caused additional burden for some. Routine haemophilia care should include psychological assessment and support for caregivers, which should be evaluated using outcome measures quantifying both HRQoL and caregiver burden.

Notes

[3] Contributed by Author contributions

SvM and KK designed the study and wrote the paper. KK recruited the child/caregiver dyads. SvM analysed the data.

[4] Financial disclosure Disclosures

KK and SvM received an unrestricted educational grant for the conduct of the study by Baxalta.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Acknowledgements

We would like to thank the parents who participated in this study for donating their time so willingly.

References

1 

2015 National Haemophilia Database Annual Returns for 2014. Available at www.ukhcdo.org last accessed 10th April 2016

National Haemophilia Database Annual Returns for 2014Available atwww.ukhcdo.orglast accessed 10th April 2016

2 

Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilia arthropathy. J Thomb Haemost 2010; 8: 1895– 902.

LA ValentinoBlood-induced joint disease: the pathophysiology of hemophilia arthropathyJ Thomb Haemost201081895902

3 

Biggs R, MacFarlane RG. Haemophilia and the related conditions: a survey of 187 cases. Br J Haematol 1958; 4: 1-27.

R BiggsRG MacFarlaneHaemophilia and the related conditions: a survey of 187 casesBr J Haematol19584127

4 

Richards M, Williams M, Chalmers E, et al.; Paediatric Working Party of the United Kingdom Haemophilia Doctors’ Organisation. A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A. Br J Haematol. 2010; 149(4): 498-507.

M RichardsM WilliamsE Chalmerset alPaediatric Working Party of the United Kingdom Haemophilia Doctors’ Organisation. A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia ABr J Haematol20101494498507

5 

Vidler V. Teaching parents advanced clinical skills. Haemophilia. 1999; 5(5): 349-53.

V VidlerTeaching parents advanced clinical skillsHaemophilia19995534953

6 

Beeton K, Neal D, Watson T, Lee CA. Parents of children with haemophilia – a transforming experience. Haemophilia. 2007; 13(5): 570-9.

K BeetonD NealT WatsonCA LeeParents of children with haemophilia – a transforming experienceHaemophilia20071355709

7 

Myrin Westesson L, Sparud-Lundin C, Wallengren C, Baghaei F. A tortuous route to a capable fatherhood: the experience of being a father to a child with severe haemophilia. Haemophilia. 2015; 21(6): 799-805.

L Myrin WestessonC Sparud-LundinC WallengrenF BaghaeiA tortuous route to a capable fatherhood: the experience of being a father to a child with severe haemophiliaHaemophilia2015216799805

8 

Myrin-Westesson L, Baghaei F, Friberg F. The experience of being a female carrier of haemophilia and the mother of a haemophilic child. Haemophilia 2013; 19(2): 219-24.

L Myrin-WestessonF BaghaeiF FribergThe experience of being a female carrier of haemophilia and the mother of a haemophilic childHaemophilia201319221924

9 

Torres-Ortuno A, Cuesta-Barriuso R, Nieto-Munuera J. Parents of children with haemophilia at an early age: assessment of perceived stress and family functioning. Haemophilia 2014; 20: 756-62.

A Torres-OrtunoR Cuesta-BarriusoJ Nieto-MunueraParents of children with haemophilia at an early age: assessment of perceived stress and family functioningHaemophilia20142075662

10 

Weidebusch S, Pollman H, Siegmund B, Muthny F. Quality of life, psychosocial strains and coping in parents of children with haemophilia. Haemophilia 2008; 14(5): 1014-22.

S WeidebuschH PollmanB SiegmundF MuthnyQuality of life, psychosocial strains and coping in parents of children with haemophiliaHaemophilia2008145101422

11 

Von Mackensen S, Gringeri A. Quality of life in haemophilia. In: Preedy VR, Watson RR (eds). Handbook of Disease Burdens and Quality of Life Measures Heidelberg: Springer; 2009. Vol 3, Chapter 12, 1895-920.

S Von MackensenA GringeriQuality of life in haemophiliaInVR PreedyRR WatsonedsHandbook of Disease Burdens and Quality of Life MeasuresHeidelbergSpringer2009Vol 3, Chapter 12, 1895-920

12 

Von Mackensen S, Gringeri A. Quality of life in hemophilia. In: Lee CA, Berntop EE, Hoots WK (eds). Textbook of Hemophilia 3rd edn. Oxford: Wiley Blackwell Publishing Ltd; 2014, 478-88.

S Von MackensenA GringeriQuality of life in hemophiliaInCA LeeEE BerntopWK HootsedsTextbook of Hemophilia3rd ednOxfordWiley Blackwell Publishing Ltd201447888

13 

Department of Health. Equity and excellence: liberating the NHS. London: HMSO; 2010. Available from https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213823/dh_117794.pdf (accessed 15 December 2016).

Department of Health. Equity and excellence: liberating the NHSLondonHMSO2010Available fromhttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213823/dh_117794.pdfaccessed 15 December 2016

14 

Szende A, Oppe M, Devlin N (eds). EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Doordrecht: Springer; 2010.

A SzendeM OppeN DevlinedsEQ-5D Value Sets: Inventory, Comparative Review and User GuideDoordrechtSpringer2010

15 

Ware J Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston, Massachussetts: The Health Institute, 1994.

J Jr WareM KosinskiSD KellerSF-36 Physical and Mental Health Summary Scales: A User’s ManualBoston, MassachussettsThe Health Institute1994

16 

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.

JE Jr WareCD SherbourneThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923047383

17 

Ravens-Sieberer U, Wille N, Badia X, et al Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res 2010; 19(6): 875-86.

U Ravens-SiebererN WilleX Badiaet alFeasibility, reliability, and validity of the EQ-5D-Y: results from a multinational studyQual Life Res201019687586

18 

Von Mackensen S, Bullinger M for The Haemo-Qol Group. Development and testing of an instrument to assess the quality of life of children with haemophilia in Europe. Haemophilia 2004, 10 (Suppl. 1): 17-25.

S Von MackensenBullinger M for The Haemo-Qol Group. Development and testing of an instrument to assess the quality of life of children with haemophilia in EuropeHaemophilia200410Suppl. 11725

19 

Stein RE, Riessman CK The development of an impact-on-family scale: preliminary findings. Med Care. 1980; 18(4): 465-72.

RE SteinRiessman CK The development of an impact-on-family scale: preliminary findingsMed Care198018446572

20 

Ravens-Sieberer U, Morfeld M, Stein RE, et al. [The testing and validation of the German version of the impact on family scale in families with children with disabilities] [Article in German]. Psychother Psychosom Med Psychol 2001; 51(9-10): 384-93.

U Ravens-SiebererM MorfeldRE Steinet al[The testing and validation of the German version of the impact on family scale in families with children with disabilities] [Article in German]Psychother Psychosom Med Psychol2001519-1038493

21 

Smith S, Cheater F, Bekker H. Parents’ experiences of living with a child with a long-term condition: a rapid structured review of the literature. Health Expect 2015; 18(4): 452-74.

S SmithF CheaterH BekkerParents’ experiences of living with a child with a long-term condition: a rapid structured review of the literatureHealth Expect201518445274

22 

Murphy NA, Christian B, Caplin DA, Young P. The health of caregivers for children with disabilities: caregiver perspectives. Child Care Health Dev 2007; 33(2): 180-7.

NA MurphyB ChristianDA CaplinP YoungThe health of caregivers for children with disabilities: caregiver perspectivesChild Care Health Dev20073321807

23 

Mullins LL, Wolfe-Christiansen C, Chaney JM, et al. The relationship between single-parent status and parenting capacities in mothers of youth with chronic health conditions: the mediating role of income. J Pediatr Psychol 2011; 36(3): 249-57.

LL MullinsC Wolfe-ChristiansenJM Chaneyet alThe relationship between single-parent status and parenting capacities in mothers of youth with chronic health conditions: the mediating role of incomeJ Pediatr Psychol201136324957

24 

Shahly V, Chatterji S, Gruber MJ, et al. Cross-national differences in the prevalence and correlates of burden among older family caregivers in the World Health Organization World Mental Health (WMH) Surveys. Psychol Med 2013; 43(4): 865–79.

V ShahlyS ChatterjiMJ Gruberet alCross-national differences in the prevalence and correlates of burden among older family caregivers in the World Health Organization World Mental Health (WMH) SurveysPsychol Med201343486579

25 

DeKoven M, Karkare S, Kelley LA, et al. Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States. Haemophilia 2014; 20(4): 541-9.

M DeKovenS KarkareLA Kelleyet alUnderstanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United StatesHaemophilia20142045419

26 

Von Mackensen S, Wisniewski T, Urgo JC, Boggio L. Pilot test of the first hemophilia-specific burden scale for caregivers of children with hemophilia in the United States—the HEMOphilia associated CAregiver Burden scale (HEMOCAB™). Journal of Thrombosis and Haemostasis 2015; 13 (Suppl. 2): PO256.

S Von MackensenT WisniewskiJC UrgoL BoggioPilot test of the first hemophilia-specific burden scale for caregivers of children with hemophilia in the United States—the HEMOphilia associated CAregiver Burden scale (HEMOCAB™)Journal of Thrombosis and Haemostasis201513Suppl. 2PO256